- Home
- WKSP vs NXTC Comparison
WKSP vs NXTC Comparison
Compare WKSP & NXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- NXTC
- Stock Information
- Founded
- WKSP 2003
- NXTC 2015
- Country
- WKSP United States
- NXTC United States
- Employees
- WKSP N/A
- NXTC N/A
- Industry
- WKSP Auto Parts:O.E.M.
- NXTC Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- NXTC Health Care
- Exchange
- WKSP Nasdaq
- NXTC Nasdaq
- Market Cap
- WKSP 14.6M
- NXTC 13.0M
- IPO Year
- WKSP N/A
- NXTC 2019
- Fundamental
- Price
- WKSP $3.41
- NXTC $7.79
- Analyst Decision
- WKSP Strong Buy
- NXTC Strong Buy
- Analyst Count
- WKSP 3
- NXTC 2
- Target Price
- WKSP $12.83
- NXTC $25.50
- AVG Volume (30 Days)
- WKSP 461.3K
- NXTC 10.5K
- Earning Date
- WKSP 11-12-2025
- NXTC 11-06-2025
- Dividend Yield
- WKSP N/A
- NXTC N/A
- EPS Growth
- WKSP N/A
- NXTC N/A
- EPS
- WKSP N/A
- NXTC N/A
- Revenue
- WKSP $12,395,166.00
- NXTC N/A
- Revenue This Year
- WKSP $159.83
- NXTC N/A
- Revenue Next Year
- WKSP $84.48
- NXTC N/A
- P/E Ratio
- WKSP N/A
- NXTC N/A
- Revenue Growth
- WKSP 232.13
- NXTC N/A
- 52 Week Low
- WKSP $2.44
- NXTC $2.69
- 52 Week High
- WKSP $12.00
- NXTC $19.20
- Technical
- Relative Strength Index (RSI)
- WKSP 48.29
- NXTC 80.45
- Support Level
- WKSP $3.40
- NXTC $6.23
- Resistance Level
- WKSP $3.70
- NXTC $6.99
- Average True Range (ATR)
- WKSP 0.33
- NXTC 0.41
- MACD
- WKSP -0.01
- NXTC 0.11
- Stochastic Oscillator
- WKSP 34.94
- NXTC 100.00
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.